Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Optimizerx Corp (OPRX)

Optimizerx Corp (OPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Optimizerx Corp 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 USA

www.optimizerx.com P: 248-651-6568

Description:

OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers marketing and advertising solutions by connecting patients, physicians, and pharmaceutical manufacturers through its consumer Websites. OptimizeRx Corporation is based in Rochester, Michigan.

Key Statistics

Overview:

Market Capitalization, $K 193,114
Enterprise Value, $K 215,494
Shares Outstanding, K 18,184
Annual Sales, $ 71,520 K
Annual Net Income, $ -17,570 K
Last Quarter Sales, $ 28,370 K
Last Quarter Net Income, $ -4,140 K
EBIT, $ -15,130 K
EBITDA, $ -12,520 K
60-Month Beta 1.05
% of Insider Shareholders 4.40%
% of Institutional Shareholders 76.47%
Float, K 17,384
% Float 95.60%
Short Volume Ratio 0.38

Growth:

1-Year Return -26.51%
3-Year Return -79.73%
5-Year Return -21.74%
5-Year Revenue Growth 237.20%
5-Year Earnings Growth -1,180.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.26 on 04/16/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -0.54
EPS Growth vs. Prev Qtr 210.00%
EPS Growth vs. Prev Year 1,000.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

OPRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -7.72%
Return-on-Assets % -6.65%
Profit Margin % -24.57%
Debt/Equity 0.29
Price/Sales 2.72
Price/Cash Flow N/A
Price/Book 1.53
Book Value/Share 6.97
Interest Coverage -16.35
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar